Abstract
CA15.3 preoperatory serum levels have been determined in 667 patients with primary untreated breast cancer and in 193 controls. The relationships between CA15.3 and several clinical and pathological parameters were evaluated. CA15.3 levels showed a highly significant direct relationship with stage, T, pT, N and the number of positive lymph nodes. The close relationship between CA15.3 and the number of positive lymph nodes was also demonstrated in a subgroup of 406 patients in which more than ten lymph nodes had been examined. CA15.3 levels were correlated with tumour size in patients without axillary metastasis as well as with the number of positive lymph nodes in pT1 tumours. CA15.3 was significantly higher in medullary than in ductal carcinoma. No relationships were found between serum CA15.3 and receptor status. We conclude from the present findings that CA15.3 in primary untreated breast cancer is a marker of tumour burden as well as of the tendency of local invasiveness (relationship between CA15.3 and nodal status in pT1 tumours).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gion, M., Mione, R., Nascimben, O. et al. The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. Br J Cancer 63, 809–813 (1991). https://doi.org/10.1038/bjc.1991.179
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.179
This article is cited by
-
A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
Surgical Case Reports (2023)
-
Intérêt clinique du dosage CA15-3 dans la surveillance du cancer du sein : à propos de 112 cas de l’Ouest algérien
Journal Africain du Cancer / African Journal of Cancer (2013)
-
Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)
Tumor Biology (2011)
-
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
British Journal of Cancer (2002)
-
TPSTM a circulating tumor marker in breast cancer
Indian Journal of Clinical Biochemistry (1999)